Overexpression of TGF-β1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease
- 9 November 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 319 (6) , F1135-F1148
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the presence of numerous fluid-filled cysts, extensive fibrosis, and the progressive decline in kidney function. Transforming growth factor-β1 (TGF-β1), an important mediator for renal fibrosis and chronic kidney disease, is overexpressed by cystic cells compared with normal kidney cells; however, its role in PKD pathogenesis remains undefined. To investigate the effect of TGF-β1 on cyst growth, fibrosis, and disease progression, we overexpressed active TGF-β1 specifically in collecting ducts (CDs) of phenotypic normal ( Pkd1RC/+) and Pkd1RC/RC mice. In normal mice, CD-specific TGF-β1 overexpression caused tubule dilations by 5 wk of age that were accompanied by increased levels of phosphorylated SMAD3, α-smooth muscle actin, vimentin, and periostin; however, it did not induce overt cyst formation by 20 wk. In Pkd1RC/RC mice, CD overexpression of TGF-β1 increased cyst epithelial cell proliferation. However, extensive fibrosis limited cyst enlargement and caused contraction of the kidneys, leading to a loss of renal function and a shortened lifespan of the mice. These data demonstrate that TGF-β1-induced fibrosis constrains cyst growth and kidney enlargement and accelerates the decline of renal function, supporting the hypothesis that a combined therapy that inhibits renal cyst growth and fibrosis will be required to effectively treat ADPKD.Keywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081579)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P30DK106912)
- PKD Foundation
This publication has 45 references indexed in Scilit:
- Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severityJournal of Clinical Investigation, 2012
- TGF-β – an excellent servant but a bad masterJournal of Translational Medicine, 2012
- Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cellsExperimental Cell Research, 2012
- Partners in crime: the TGFβ and MAPK pathways in cancer progressionCell & Bioscience, 2011
- Cyclic AMP-mediated cyst expansionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Conditional overexpression of TGF-β1 disrupts mouse salivary gland development and functionLaboratory Investigation, 2010
- Transforming Growth Factor β1 Inhibits Cystic Fibrosis Transmembrane Conductance Regulator-dependent cAMP-stimulated Alveolar Epithelial Fluid Transport via a Phosphatidylinositol 3-Kinase-dependent MechanismJournal of Biological Chemistry, 2010
- Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networksHuman Molecular Genetics, 2009
- TGF-β Mediated Epithelial-Mesenchymal Transition in Autosomal Dominant Polycystic Kidney DiseaseYonsei Medical Journal, 2009
- Periostin induces proliferation of human autosomal dominant polycystic kidney cells through αV-integrin receptorAmerican Journal of Physiology-Renal Physiology, 2008